Advertisement
Advertisement

LRMR

LRMR logo

Larimar Therapeutics, Inc. Common Stock

3.97
USD
Sponsored
-0.03
-0.75%
May 08, 15:58 UTC -4
Closed
exchange

Pre-Market

3.96

-0.01
-0.35%

Larimar Therapeutics, Inc. Common Stock Profile

About

Larimar Therapeutics Inc. is a clinical-stage biotechnology company. It is focused on developing treatments for rare diseases. The company's lead product consist CTI-1601, which is in clinical stage. Larimar Therapeutics Inc., formerly known as Zafgen Inc., is based in BALA CYNWYD, Pa.

Info & Links

CEO

Carole S. Ben-Maimon

Headquarters

THREE BALA PLAZA EAST. SUITE 506
BALA CYNWYD, PA 19004, UNITED STATES

Industry

Medical Drugs

Sector

Medical

Website

https://larimartx.com

Auditor

PricewaterhouseCoopers LLP

Share holders

--

Employees

71

Larimar Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

410.96M

Enterprise Value

325.55M

Enterprise Value/EBITDA(ttm)

-1.87

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

5.40

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-137.70%

Return on Invested Capital(ttm)

-156.49%

Return on Assets(ttm)

-101.43%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-173.84M

Net Income Available to Common(ttm)

-165.67M

Diluted EPS(ttm)

-2.21

Share Statistics

Beta (5Y Monthly)

1.02

52-Week Change

87.26%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

103.88M

Dividend Yield

0.00%

Float4

99.21M

% Held by Insiders

4.50%

% Held by Institutions

91.92%

Balance Sheet

Total Cash(mrq)

136.85M

Total Cash Per Share(mrq)

1.32

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

2.19%

Quick Ratio(mrq)

2.19%

Book Value Per Share(mrq)

0.94

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.55

Free Cash Flow(ytd)

-113.29M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement